[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade)",
    "summary": "Vertex Pharmaceuticals Incorporated's stock drop is overblown. With strong CF revenue, pipeline potential, & insider confidence, click for why VRTX stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=33e219893e5ff70d5426b444ee5aa22e2dd7a6608d34f9b1f1e8f72f4863156f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754930844,
      "headline": "Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade)",
      "id": 136311902,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1372801568/image_1372801568.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Vertex Pharmaceuticals Incorporated's stock drop is overblown. With strong CF revenue, pipeline potential, & insider confidence, click for why VRTX stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=33e219893e5ff70d5426b444ee5aa22e2dd7a6608d34f9b1f1e8f72f4863156f"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie’s upadacitinib raises the bar for alopecia areata",
    "summary": "Key opinion leaders (KOLs) interviewed by GlobalData have expressed the need for therapies with higher efficacy to improve clinical outcomes in patients with alopecia areata.",
    "url": "https://finnhub.io/api/news?id=e9fb69178bd01dba80029f504bd96f5284bdded6b3ae771aeeb006397dbe11c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754928439,
      "headline": "AbbVie’s upadacitinib raises the bar for alopecia areata",
      "id": 136310515,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Key opinion leaders (KOLs) interviewed by GlobalData have expressed the need for therapies with higher efficacy to improve clinical outcomes in patients with alopecia areata.",
      "url": "https://finnhub.io/api/news?id=e9fb69178bd01dba80029f504bd96f5284bdded6b3ae771aeeb006397dbe11c2"
    }
  },
  {
    "ts": null,
    "headline": "Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth",
    "summary": "Multiple Myeloma is a cancer affecting plasma cells in bone marrow, often leading to weakened bones, anemia, and kidney damage. The production of abnormal M-proteins is a disease hallmark, detectable in blood or urine. While incurable, treatment advancements like chemotherapy, immunotherapy, and CAR T-cell therapy enhance patient outcomes. Market growth is driven by innovative immunotherapies, yet challenges like high treatment costs, resistance, and late diagnosis persist. Key players such as J",
    "url": "https://finnhub.io/api/news?id=9b792f2d80db8c118ae6948862869b5f26d134d3d1926bdd311f297bfab8402d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754905080,
      "headline": "Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth",
      "id": 136292450,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Multiple Myeloma is a cancer affecting plasma cells in bone marrow, often leading to weakened bones, anemia, and kidney damage. The production of abnormal M-proteins is a disease hallmark, detectable in blood or urine. While incurable, treatment advancements like chemotherapy, immunotherapy, and CAR T-cell therapy enhance patient outcomes. Market growth is driven by innovative immunotherapies, yet challenges like high treatment costs, resistance, and late diagnosis persist. Key players such as J",
      "url": "https://finnhub.io/api/news?id=9b792f2d80db8c118ae6948862869b5f26d134d3d1926bdd311f297bfab8402d"
    }
  },
  {
    "ts": null,
    "headline": "Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations",
    "summary": "The Non-metastatic Prostate Cancer market is witnessing substantial growth driven by increasing demand for targeted therapies and innovative treatment options. Non-metastatic prostate cancer, confined to the prostate gland, benefits from early detection methods like PSA testing and multiparametric MRI, facilitating timely intervention. Key players like Johnson & Johnson, Astellas Pharma, and Pfizer are pioneering advancements with androgen receptor inhibitors and precision medicine. Despite sign",
    "url": "https://finnhub.io/api/news?id=7ed66726fb860b103f275cf311c614095bcaca667705b72b586e98df5fdd96f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754903580,
      "headline": "Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations",
      "id": 136292298,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The Non-metastatic Prostate Cancer market is witnessing substantial growth driven by increasing demand for targeted therapies and innovative treatment options. Non-metastatic prostate cancer, confined to the prostate gland, benefits from early detection methods like PSA testing and multiparametric MRI, facilitating timely intervention. Key players like Johnson & Johnson, Astellas Pharma, and Pfizer are pioneering advancements with androgen receptor inhibitors and precision medicine. Despite sign",
      "url": "https://finnhub.io/api/news?id=7ed66726fb860b103f275cf311c614095bcaca667705b72b586e98df5fdd96f9"
    }
  }
]